Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Cancer Stem-Cell Marker CD44v9-Positive Cells Arise From Helicobacter pylori-Infected CAPZA1-Overexpressing Cells.

Tsugawa H, Kato C, Mori H, Matsuzaki J, Kameyama K, Saya H, Hatakeyama M, Suematsu M, Suzuki H.

Cell Mol Gastroenterol Hepatol. 2019;8(3):319-334. doi: 10.1016/j.jcmgh.2019.05.008. Epub 2019 May 27.

2.

CAPZA1 determines the risk of gastric carcinogenesis by inhibiting Helicobacter pylori CagA-degraded autophagy.

Tsugawa H, Mori H, Matsuzaki J, Sato A, Saito Y, Imoto M, Suematsu M, Suzuki H.

Autophagy. 2019 Feb;15(2):242-258. doi: 10.1080/15548627.2018.1515530. Epub 2018 Sep 10.

3.

Chronic inflammation with Helicobacter pylori infection is implicated in CD44 overexpression through miR-328 suppression in the gastric mucosa.

Ishimoto T, Izumi D, Watanabe M, Yoshida N, Hidaka K, Miyake K, Sugihara H, Sawayama H, Imamura Y, Iwatsuki M, Iwagami S, Baba Y, Horlad H, Komohara Y, Takeya M, Baba H.

J Gastroenterol. 2015 Jul;50(7):751-7. doi: 10.1007/s00535-014-1019-y. Epub 2014 Dec 6.

PMID:
25479940
4.

Nuclear translocation of β-catenin correlates with CD44 upregulation in Helicobacter pylori-infected gastric carcinoma.

Udhayakumar G, Jayanthi V, Devaraj N, Devaraj H.

Mol Cell Biochem. 2011 Nov;357(1-2):283-93. doi: 10.1007/s11010-011-0899-x. Epub 2011 Jun 16.

PMID:
21678082
5.

β-Catenin and p120 mediate PPARδ-dependent proliferation induced by Helicobacter pylori in human and rodent epithelia.

Nagy TA, Wroblewski LE, Wang D, Piazuelo MB, Delgado A, Romero-Gallo J, Noto J, Israel DA, Ogden SR, Correa P, Cover TL, Peek RM Jr.

Gastroenterology. 2011 Aug;141(2):553-64. doi: 10.1053/j.gastro.2011.05.004. Epub 2011 May 17.

6.

Helicobacter pylori upregulates Nanog and Oct4 via Wnt/β-catenin signaling pathway to promote cancer stem cell-like properties in human gastric cancer.

Yong X, Tang B, Xiao YF, Xie R, Qin Y, Luo G, Hu CJ, Dong H, Yang SM.

Cancer Lett. 2016 May 1;374(2):292-303. doi: 10.1016/j.canlet.2016.02.032. Epub 2016 Mar 2.

7.

CD44 variant isoform 9 emerges in response to injury and contributes to the regeneration of the gastric epithelium.

Bertaux-Skeirik N, Wunderlich M, Teal E, Chakrabarti J, Biesiada J, Mahe M, Sundaram N, Gabre J, Hawkins J, Jian G, Engevik AC, Yang L, Wang J, Goldenring JR, Qualls JE, Medvedovic M, Helmrath MA, Diwan T, Mulloy JC, Zavros Y.

J Pathol. 2017 Aug;242(4):463-475. doi: 10.1002/path.4918.

8.

CD44 variant 9 expression as a predictor for gastric cancer recurrence: immunohistochemical and metabolomic analysis of surgically resected tissues.

Yamakawa Y, Kusuhara M, Terashima M, Kinugasa Y, Sugino T, Abe M, Mochizuki T, Hatakeyama K, Kami K, Yamaguchi K.

Biomed Res. 2017;38(1):41-52. doi: 10.2220/biomedres.38.41.

9.

Acetylation of apurinic/apyrimidinic endonuclease-1 regulates Helicobacter pylori-mediated gastric epithelial cell apoptosis.

Bhattacharyya A, Chattopadhyay R, Burnette BR, Cross JV, Mitra S, Ernst PB, Bhakat KK, Crowe SE.

Gastroenterology. 2009 Jun;136(7):2258-69. doi: 10.1053/j.gastro.2009.02.014.

10.

Clinical significance of CD44 variant 9 expression as a prognostic indicator in bladder cancer.

Kobayashi K, Matsumoto H, Matsuyama H, Fujii N, Inoue R, Yamamoto Y, Nagao K.

Oncol Rep. 2016 Nov;36(5):2852-2860. doi: 10.3892/or.2016.5061. Epub 2016 Sep 1.

PMID:
27599396
11.

CD44 plays a functional role in Helicobacter pylori-induced epithelial cell proliferation.

Bertaux-Skeirik N, Feng R, Schumacher MA, Li J, Mahe MM, Engevik AC, Javier JE, Peek RM Jr, Ottemann K, Orian-Rousseau V, Boivin GP, Helmrath MA, Zavros Y.

PLoS Pathog. 2015 Feb 6;11(2):e1004663. doi: 10.1371/journal.ppat.1004663. eCollection 2015 Feb.

12.

Helicobacter pylori Depletes Cholesterol in Gastric Glands to Prevent Interferon Gamma Signaling and Escape the Inflammatory Response.

Morey P, Pfannkuch L, Pang E, Boccellato F, Sigal M, Imai-Matsushima A, Dyer V, Koch M, Mollenkopf HJ, Schlaermann P, Meyer TF.

Gastroenterology. 2018 Apr;154(5):1391-1404.e9. doi: 10.1053/j.gastro.2017.12.008. Epub 2017 Dec 19.

13.

Helicobacter pylori decreases p27 expression through the delta opioid receptor-mediated inhibition of histone acetylation within the p27 promoter.

Byun SW, Chang YJ, Chung IS, Moss SF, Kim SS.

Cancer Lett. 2012 Dec 29;326(1):96-104. doi: 10.1016/j.canlet.2012.07.032. Epub 2012 Aug 4.

14.

CAPZA1 modulates EMT by regulating actin cytoskeleton remodelling in hepatocellular carcinoma.

Huang D, Cao L, Zheng S.

J Exp Clin Cancer Res. 2017 Jan 16;36(1):13. doi: 10.1186/s13046-016-0474-0.

15.

Expression of CD44 containing variant exon 9 (CD44v9) in gastric adenomas and adenocarcinomas: relation to the proliferation and progression.

Yasui W, Kudo Y, Naka K, Fujimoto J, Ue T, Yokozaki H, Tahara E.

Int J Oncol. 1998 Jun;12(6):1253-8.

PMID:
9592182
16.
17.

Prognostic value of CAPZA1 overexpression in gastric cancer.

Lee YJ, Jeong SH, Hong SC, Cho BI, Ha WS, Park ST, Choi SK, Jung EJ, Ju YT, Jeong CY, Kim JW, Lee CW, Yoo J, Ko GH.

Int J Oncol. 2013 May;42(5):1569-77. doi: 10.3892/ijo.2013.1867. Epub 2013 Mar 27.

18.

Initiation and Maintenance of Gastric Cancer: A Focus on CD44 Variant Isoforms and Cancer Stem Cells.

Zavros Y.

Cell Mol Gastroenterol Hepatol. 2017 Mar 14;4(1):55-63. doi: 10.1016/j.jcmgh.2017.03.003. eCollection 2017 Jul. Review.

19.

CD44 variant 9 is a potential biomarker of tumor initiating cells predicting survival outcome in hepatitis C virus-positive patients with resected hepatocellular carcinoma.

Kakehashi A, Ishii N, Sugihara E, Gi M, Saya H, Wanibuchi H.

Cancer Sci. 2016 May;107(5):609-18. doi: 10.1111/cas.12908. Epub 2016 Mar 28.

20.

In silico chemical screening identifies epidermal growth factor receptor as a therapeutic target of drug-tolerant CD44v9-positive gastric cancer cells.

Mashima T, Iwasaki R, Kawata N, Kawakami R, Kumagai K, Migita T, Sano T, Yamaguchi K, Seimiya H.

Br J Cancer. 2019 Nov;121(10):846-856. doi: 10.1038/s41416-019-0600-9. Epub 2019 Oct 14.

PMID:
31607750

Supplemental Content

Support Center